News & Events

News &

Virtual Panel Of Cantor And Fitzgerald Will Discuss Market Opportunities In Ophthalmic Indications, Hosting Tarsier Pharma

08 June, 2022

Tarsier pharma is pleased to contribute to the video call “Eyeing Key Events and Programs in the Ophthalmology Space in 2022” initiated by Cantor and Fitzgerald, a global financial services firm, that would take place on Wednesday, 8th of June 2022, 10:00am EST. The virtual meeting would be moderated by Ms. Kristen Kluska, Biotechnology Research Analyst, and host leaders of four ophthalmic-oriented companies, Lineage Cell Therapeutics, Ocuphire Pharma, Outlook Therapeutics and Tarsier Pharma. Panelists will discuss market opportunities across numerous indications in the ophthalmology space and share highlights about company pipelines, progress & programs, and upcoming milestones and events.

If interested in listening to the call please contact your Cantor Representative.

Scroll to Top